Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
-10.41% (1D)
Bid | 0.44 |
Market Cap | 18.75M |
Revenue (ttm) | 16.23M |
Net Income (ttm) | -50.77M |
EPS (ttm) | -1.22 |
PE Ratio (ttm) | -0.37 |
Forward PE | -0.68 |
Analyst | Hold |
Ask | 0.44 |
Volume | 2,680,813 |
Avg. Volume (20D) | 13,863,579 |
Open | 0.48 |
Previous Close | 0.50 |
Day's Range | 0.43 - 0.56 |
52-Week Range | 0.14 - 1.90 |
Beta | 2.79 |
About CARM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CARM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CARM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Carisma Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-25.65%
Carisma Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
6 months ago
-12.82%
Carisma Therapeutics shares are trading lower after Baird downgraded the stock from Outperform to Neutral and cut its price target from $10 to $1.